The FDA has expanded the label of Ozempic, approving the Novo Nordisk product for reducing the risk of worsening kidney disease and kidney failure as well as reducing the risk of death.

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Semaglutide was a top-selling drug in 2023, and its popularity only continues to grow, as it’s been increasingly prescribed off-label for weight loss. Read on to learn more about Ozempic ...

The FDA expanded Ozempic’s label last week, clearing Novo to market ... Spherix said. Many of the same products featured in GlobalData’s recent analysis of the heart failure market.

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight ... In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) reported ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds. Now, a new study finds that Ozempic, along with similar drugs such ...